Villgro adds Windmill Health Technologies to its incubation portfolio
Windmill Health, co-founded by Avijit Bansal and Ayesha Chaudhary, Stanford India Biodesign Fellows of 2011, is a start-up dedicated to the innovation of low-cost technology that creates a high impact on health in the developing world. The company’s first innovation is NeoBreathe, an affordable, neonatal resuscitation device enabling frontline health workers to resuscitate newborns effectively.
In a recent announcement, Villgro has added Windmill into its incubation portfolio. Villgro will make an equity investment in Windmill Health Technologies and provide mentoring, talent and access to relevant networks, to help the enterprise execute and grow.
NeoBreathe is an integrated device incorporating several innovative features that overcome flaws in existing neonatal care devices, making it suitable for field conditions. It will empower frontline workers to perform neonatal resuscitation effectively with minimal training. Unlike existing devices, it enables a single person to perform resuscitation, an important advantage given the shortage of skilled professionals in developing countries.
“We are excited by the impact this simple device will have in saving the lives of babies,” said Paul Basil, Founder and CEO of Villgro. “We are also looking forward to working with the entrepreneurs – a biodesign expert and a doctor – who are passionate and motivated.”
